Mangoceuticals Inc (MGRX)
Mangoceuticals, Inc. is a U.S.-based company focused on men’s wellness through a telemedicine platform. It develops, markets, and sells products and services tied to areas such as erectile dysfunction, hair loss, hormone balance and therapy, weight management, and testosterone replacement. The company’s portfolio includes products sold under the Mango, Grow, Mojo, Slim, and Prime brands, and it also provides customers with access to a licensed pharmacy for online fulfillment of medications that may be prescribed during telehealth consultations. Mangoceuticals sells its products through its website, MangoRX.com. Incorporated in 2021, the company is headquartered in Dallas, Texas, and is a subsidiary of Cohen Enterprises, Inc.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-MGRX
|
$0.46
|
6.2% Upside
|
Fair
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 18, 2026
|
-0.4x
|
0.5x
|
17.8x
|
7.229 M
|
7.503 M
|
3.9%
|
78.2%
|
-231.3
|
—
|
24.0%
|
